BMB Reports : eISSN 1976-670X

Cited by CrossRef (17)

  1. Hirohito Yamaguchi, Jung-Mao Hsu, Wen-Hao Yang, Mien-Chie Hung. Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics. Nat Rev Clin Oncol 2022;19:287
    https://doi.org/10.1038/s41571-022-00601-9
  2. An’an Xu, Jeehyun Lee, Yueling Zhao, Yuefei Wang, Xiaoli Li, Ping Xu. Potential effect of EGCG on the anti-tumor efficacy of metformin in melanoma cells. J. Zhejiang Univ. Sci. B 2021;22:548
    https://doi.org/10.1631/jzus.B2000455
  3. Xiao-yu Wu, Wen-Wen Xu, Xiang-kun Huan, Guan-nan Wu, Gang Li, Yu-Hong Zhou, Masoud Najafi. Mechanisms of cancer cell killing by metformin: a review on different cell death pathways. Mol Cell Biochem 2023;478:197
    https://doi.org/10.1007/s11010-022-04502-4
  4. Marc Foretz, Bruno Guigas, Benoit Viollet. Metformin: update on mechanisms of action and repurposing potential. Nat Rev Endocrinol 2023;19:460
    https://doi.org/10.1038/s41574-023-00833-4
  5. Jaedeok Kim, Nayoung Lee, Sang Bum Suh, Sooyeon Jang, Saeha Kim, Dong-Gyu Kim, Jong Kook Park, Keun-Wook Lee, Soo Young Choi, Chan Hee Lee. Metformin ameliorates olanzapine-induced disturbances in POMC neuron number, axonal projection, and hypothalamic leptin resistance. BMB Rep 2022;55:293
    https://doi.org/10.5483/BMBRep.2022.55.6.026
  6. Devika Rajeev, Nancie J. MacIver. Metformin as a therapeutic agent for obesity-associated immune dysfunction. The Journal of Nutrition 2024
    https://doi.org/10.1016/j.tjnut.2024.07.001
  7. Wenjiao Xia, Xin Qi, Mingfeng Li, Yu Wu, Lulu Sun, Xinglong Fan, Yuan Yuan, Jing Li. Metformin promotes anticancer activity of NK cells in a p38 MAPK dependent manner. OncoImmunology 2021;10
    https://doi.org/10.1080/2162402X.2021.1995999
  8. Xiuman Zhou, Ling Jiao, Yuzhen Qian, Qingyu Dong, Yixuan Sun, Wei V. Zheng, Wenshan Zhao, Wenjie Zhai, Lu Qiu, Yahong Wu, Hongfei Wang, Yanfeng Gao, Junhui Chen. Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47/SIRPα and TIGIT/PVR Pathways for Cancer Immuno-Therapy. Biomolecules 2021;11:706
    https://doi.org/10.3390/biom11050706
  9. Shiyue Zhou, Zixuan Zhao, Hao Zhong, Zehao Ren, Yuye Li, Hong Wang, Yuling Qiu. The role of myeloid-derived suppressor cells in liver cancer. Discov Onc 2023;14
    https://doi.org/10.1007/s12672-023-00681-8
  10. Mingo M. H. Yung, Michelle K. Y. Siu, Hextan Y. S. Ngan, David W. Chan, Karen K. L. Chan. Orchestrated Action of AMPK Activation and Combined VEGF/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian Cancers. IJMS 2022;23:6857
    https://doi.org/10.3390/ijms23126857
  11. Abdul Samee Ali, Khurram Tahir, Bolam Kim, Youngsu Lim, Dae Sung Lee. Microbially catalyzed anode and cathode microbial electrosynthesis system for efficient metformin removal and volatile fatty acid production. Fuel 2024;358:130237
    https://doi.org/10.1016/j.fuel.2023.130237
  12. Akira Saito, Koji Koinuma, Rie Kawashima, Hideyo Miyato, Hideyuki Ohzawa, Hisanaga Horie, Hironori Yamaguchi, Hiroshi Kawahira, Toshiki Mimura, Joji Kitayama, Naohiro Sata. Metformin may improve the outcome of patients with colorectal cancer and type 2 diabetes mellitus partly through effects on neutrophil extracellular traps. BJC Rep 2023;1
    https://doi.org/10.1038/s44276-023-00022-w
  13. Raymond Chang. Drug Repurposing - Molecular Aspects and Therapeutic Applications. 2023.
    https://doi.org/10.5772/intechopen.96101
  14. Runxian Wang, Zhenya Liu, Zhiyao Fan, Hanxiang Zhan. Lipid metabolism reprogramming of CD8+ T cell and therapeutic implications in cancer. Cancer Letters 2023;567:216267
    https://doi.org/10.1016/j.canlet.2023.216267
  15. Holya A. Lafta, Ali H. AbdulHussein, Saif A. J. Al-Shalah, Yasir S. Alnassar, Naseer M. Mohammed, Sally M. Akram, Maytham T. Qasim, Masoud Najafi. Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products. CTMC 2023;23:1104
    https://doi.org/10.2174/1568026623666230201145909
  16. Jianhong Liu, Ming Zhang, Dan Deng, Xiao Zhu. The function, mechanisms, and clinical applications of metformin: potential drug, unlimited potentials. Arch. Pharm. Res. 2023;46:389
    https://doi.org/10.1007/s12272-023-01445-2
  17. Yu-Ting Ma, Lu Zheng, Cheng-Wen Zhao, Yue Zhang, Xin-Wei Xu, Xin-Yu Wang, Guo-Ping Niu, Zhong-Song Man, Feng Gu, Yong-Qiang Chen. Interferon-α induces differentiation of cancer stem cells and immunosuppression in hepatocellular carcinoma by upregulating CXCL8 secretion. Cytokine 2024;177:156555
    https://doi.org/10.1016/j.cyto.2024.156555